References
- Wagner J C. Mesothelioma and mineral fibers. Cancer 1986; 57: 1905–1911
- McDonald A D, McDonald J C. Malignant mesothelioma in North America. Cancer 1980; 46: 1650–1656
- Botha J L, Irwig L M, Strebel P M. Excess mortality from stomach cancer, lung cancer, and asbestosis and/or mesothelioma in crocidolite mining districts in South Africa. Am J Epidemiol. 1986; 123: 30–40
- Sluis-Cremer G K, Liddell FDK, Logan WPD, Bezuidenhout B N. The mortality of amphibole miners in South Africa, 1946-80. Br J Ind Med. 1992; 49: 566–575
- Hansen J, de Klerk N H, Eccles J L, Musk W, Hobbs MST. Malignant mesothelioma after environmental exposure to blue asbestos. Int J Cancer. 1993; 54: 578–581
- McConnochie K, Simonato L, Mavrides P, Christofides P, Pooley F D, Wagner J C. Mesothelioma in Cyprus; the role of tremolite. Thorax. 1987; 42: 342–347
- Mancuso T F. Relative risk of mesothelioma among railroad machinists exposed to chrysotile. Am J Ind Med. 1988; 13: 639–657
- Spirtas R, Heineman E F, Bernstein L, et al. Malignant mesothelioma: attributable, risk of asbestos exposure. Occup Environ Med. 1994; 51: 804–811
- Gelder T V, Hoogsteden H C, Versnel M A, de Beer P H, Van-Denbroucke J P, Planteydt H T. Malignant peritoneal mesothelioma: a series of 19 cases. Digestion 1989; 43: 222–227
- Fitzpatrick D R, Peroni D J, Bielefeldt-Ohmann H. The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma. Am J Respir Cell Mol Biol. 1995; 12: 455–460
- Peto J, Hodgson J T, Matthews F E, Jones J R. Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345: 535–539, Abstract
- Wagner J C, Pooley F D. Mineral fibres and mesothelioma. Thorax. 1986; 41: 161–166
- Srebro S H, Roggli V L. Asbestos-related disease associated with exposure to asbestiform tremolite. Am J Ind Med. 1994; 26: 809–819
- Lippmann M. Deposition and retention of inhaled fibres: effects on incidence of lung cancer and mesothelioma. Occup Environ Med. 1994; 51: 793–798
- Mossman B T, Bignon J, Corn M, Seaton A, Gee JBL. Asbestos: scientific developments and implications for public policy. Science 1990; 247: 294–301
- Becklake M R, Churg A, Rosenstock L, Weill H. Mesothelioma update for clinicians. Am Rev Respir Dis. 1986; 134: 1042–1045
- Dodson R F, Williams M G, Corn C J, Brollo A, Bianchi C. A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques. Ann NY Acad Sci. 1991; 643: 53–60
- Churg A, Vedal S. Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. Am J Respir Crit Care Med. 1994; 150: 663–669
- Stanton M F, Layard M, Tegeris E, et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 1981; 67: 965
- Stanton M F, Layard M, Tegeris A, Miller E, May M, Kent E. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst. 1977; 58: 587–603
- Timbrell V, Skidmore J W. Significance of fiber length in experimental asbestosis. Internationale Konferenz der biologische Wirkungen des Asbestes, Dresden, E Holstein, M. Anspach. Dtsch Zentralinst Abeitsmed, Berlin 1968; 52–56
- Lippmann M. Asbestos exposure indices. Environ Res. 1988; 46: 86–106
- Lippmann M. Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect. 1990; 88: 311–317
- Hammar S P. Pleural diseases. Pulmonary Pathology, DH Dail, SP Hammar. Springer, New York 1994; 1463–1580
- Henderson D W, Shilkin K B, Whitaker D, . The pathology of malignant mesothelioma, including immunohistology and ultrastructure. Malignant Mesothelioma, DW Henderson, KB Shilkin, SLP Langlois, D Whitaker, et al. Hemisphere, New York 1992; 69–139
- Craighead J E, Abraham J L, Churg A, et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Arch Pathol Lab Med. 1982; 106: 544–596
- Smith M J, Naylor B. A method of extracting ferruginous bodies from sputum and pulmonary tissue. Am J Clin Pathol. 1972; 58: 250–254
- Williams M G, Dodson R F, Corn C, Hurst G A. A procedure for the isolation of amosite asbestos and ferruginous bodies from lung tissue and sputum. J Toxicol Environ Health 1982; 10: 627–638
- Jaffe M S. Handling and washing fragile replicas. J Appl Phys. 1948; 19: 1187, Abstract
- Churg A, Warnock M L. Correlation of quantitative asbestos body counts and occupation in urban patients. Arch Pathol Lab Med. 1977; 101: 629–634
- Roggli V L, Pratt P C, Brody A R. Asbestos content of lung tissue in asbestos associated diseases: a study of 110 cases. Br J Ind Med. 1986; 43: 18–28
- Roggli V L, Benning T L. Asbestos bodies in pulmonary hilar lymph nodes. Mod Pathol. 1990; 3: 513–517
- Breedin P H, Buss D H. Ferruginous (asbestos) bodies in the lungs of rural dwellers, urban dwellers and patients with pulmonary neoplasms. South Med J. 1976; 69: 401–404
- Dodson R F, Greenberg S D, Williams M G, Corn C J, O'Sullivan M F, Hurst G A. Asbestos content in lungs of occupationally and nonoccupationally exposed individuals. JAMA 1984; 252: 68–71
- Dodson R F, O'Sullivan M F, Corn C J. Technique dependent variations in asbestos burden as illustrated in a case of nonoccupational exposed mesothelioma. Am J Ind Med. 1993; 24: 235–240
- Hammar S P, Dodson R F. Asbestos. Pulmonary Pathology, DH Dail, SP Hammar. Springer, New York 1994; 901–983
- Churg A, Wiggs B, Depaoli L, Kampe B, Stevens B. Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis. 1984; 130: 1042–1045
- Churg A, Wright J L, Vedal S. Fiber burden and patterns of asbestos-related disease in chrysotile miners and millers. Am Rev Respir Dis. 1993; 148: 25–31, Abstract
- Dufresne A, Harrigan M, Masse S, Begin R. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec. Am J Ind Med. 1995; 27: 581–592, Abstract
- Stanton M F, Wrench C. Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst. 1972; 48: 797–821
- Warnock M L, Isenberg W. Asbestos burden and the pathology of lung cancer. Chest 1986; 89: 20–26
- Leigh J, Rogers A J, Ferguson D A, Mulder H B, Ackad M, Thompson R. Lung asbestos fiber content and mesothelioma cell type, site, and survival. Cancer 1991; 68: 135–141, Abstract
- Wagner J C. The discovery of the association between blue asbestos and mesotheliomas and the aftermath. Br J Ind Med. 1991; 48: 399–403
- Selikoff I J, Churg J. Carcinogenicity of amosite asbestos. Arch Environ Health 1972; 25: 183–186, Abstract
- Roggli V L, Pratt P C, Brody A R. Asbestos fiber type in malignant mesothelioma: an analytical scanning electron microscopic study of 94 cases. Br J Ind Med. 1993; 23: 605–614, Abstract
- Dodson R F, Williams M G, O'Sullivan M F, Corn C J, Greenberg S D, Hurst G A. A comparison of the ferruginous body and uncoated fiber content in the lungs of former asbestos workers. Am Rev Respir Dis. 1985; 132: 143–147
- Meurman L O, Pukkala E, Hakama M. Incidence of cancer among anthophyllite asbestos miners in Finland. Occup Environ Med. 1994; 51: 421–425, Abstract
- Karjalainen A, Meurman L O, Pukkala E. Four cases of mesothelioma among Finnish anthophyllite miners. Occup Environ Med. 1994; 51: 212–215, Abstract